Pharmaids Pharmaceuticals Ltd — Important, 18-09-2025: Company Update

Pharmaids Pharmaceuticals has completed the sale of its entire 66.50% partnership stake in Anugraha Chemicals for a cash consideration of 0.0665 Cr. This disinvestment, approved by shareholders, means Anugraha Chemicals is no longer a material subsidiary. Anugraha Chemicals contributed significantly to Pharmaids’ last financial year, accounting for 68.91% of consolidated revenue (13.40 Cr) and 6.80% of consolidated net worth (3.74 Cr). The total value of the disinvestment, including loans and other dues to be received later, was previously indicated as 10.50 Cr, streamlining Pharmaids' operations.